Cargando…
Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354373/ https://www.ncbi.nlm.nih.gov/pubmed/32663514 http://dx.doi.org/10.1016/j.clim.2020.108542 |
| _version_ | 1783558071508795392 |
|---|---|
| author | McIlroy, James R. Mullish, Benjamin H. Goldenberg, Simon D. Ianiro, Gianluca Marchesi, Julian R. |
| author_facet | McIlroy, James R. Mullish, Benjamin H. Goldenberg, Simon D. Ianiro, Gianluca Marchesi, Julian R. |
| author_sort | McIlroy, James R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7354373 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73543732020-07-13 Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′ McIlroy, James R. Mullish, Benjamin H. Goldenberg, Simon D. Ianiro, Gianluca Marchesi, Julian R. Clin Immunol Article Elsevier Inc. 2020-09 2020-07-12 /pmc/articles/PMC7354373/ /pubmed/32663514 http://dx.doi.org/10.1016/j.clim.2020.108542 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article McIlroy, James R. Mullish, Benjamin H. Goldenberg, Simon D. Ianiro, Gianluca Marchesi, Julian R. Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′ |
| title | Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′ |
| title_full | Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′ |
| title_fullStr | Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′ |
| title_full_unstemmed | Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′ |
| title_short | Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′ |
| title_sort | intestinal microbiome transfer, a novel therapeutic strategy for covid-19 induced hyperinflammation?: in reply to, ‘covid-19: immunology and treatment options’, felsenstein, herbert mcnamara et al. 2020′ |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354373/ https://www.ncbi.nlm.nih.gov/pubmed/32663514 http://dx.doi.org/10.1016/j.clim.2020.108542 |
| work_keys_str_mv | AT mcilroyjamesr intestinalmicrobiometransferanoveltherapeuticstrategyforcovid19inducedhyperinflammationinreplytocovid19immunologyandtreatmentoptionsfelsensteinherbertmcnamaraetal2020 AT mullishbenjaminh intestinalmicrobiometransferanoveltherapeuticstrategyforcovid19inducedhyperinflammationinreplytocovid19immunologyandtreatmentoptionsfelsensteinherbertmcnamaraetal2020 AT goldenbergsimond intestinalmicrobiometransferanoveltherapeuticstrategyforcovid19inducedhyperinflammationinreplytocovid19immunologyandtreatmentoptionsfelsensteinherbertmcnamaraetal2020 AT ianirogianluca intestinalmicrobiometransferanoveltherapeuticstrategyforcovid19inducedhyperinflammationinreplytocovid19immunologyandtreatmentoptionsfelsensteinherbertmcnamaraetal2020 AT marchesijulianr intestinalmicrobiometransferanoveltherapeuticstrategyforcovid19inducedhyperinflammationinreplytocovid19immunologyandtreatmentoptionsfelsensteinherbertmcnamaraetal2020 |